FR3089224B1 - Composition auto-moussante en milieu acide et procédé de préparation - Google Patents

Composition auto-moussante en milieu acide et procédé de préparation Download PDF

Info

Publication number
FR3089224B1
FR3089224B1 FR1872320A FR1872320A FR3089224B1 FR 3089224 B1 FR3089224 B1 FR 3089224B1 FR 1872320 A FR1872320 A FR 1872320A FR 1872320 A FR1872320 A FR 1872320A FR 3089224 B1 FR3089224 B1 FR 3089224B1
Authority
FR
France
Prior art keywords
self
preparation
foaming composition
acid medium
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1872320A
Other languages
English (en)
Other versions
FR3089224A1 (fr
Inventor
Jean-Michel Simon
Stéphane Roger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jellynov
Original Assignee
Jellynov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jellynov filed Critical Jellynov
Priority to FR1872320A priority Critical patent/FR3089224B1/fr
Priority to PCT/EP2019/083310 priority patent/WO2020114966A1/fr
Priority to EP19812775.5A priority patent/EP3891188A1/fr
Publication of FR3089224A1 publication Critical patent/FR3089224A1/fr
Application granted granted Critical
Publication of FR3089224B1 publication Critical patent/FR3089224B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/163Sugars; Polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/40Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734Alginic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/04Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
    • C08J9/06Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a chemical blowing agent
    • C08J9/08Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a chemical blowing agent developing carbon dioxide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/16Making expandable particles
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/22After-treatment of expandable particles; Forming foamed products
    • C08J9/224Surface treatment
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00Foams characterised by the foaming process
    • C08J2201/02Foams characterised by the foaming process characterised by mechanical pre- or post-treatments
    • C08J2201/026Crosslinking before of after foaming
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2203/00Foams characterized by the expanding agent
    • C08J2203/02CO2-releasing, e.g. NaHCO3 and citric acid
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2207/00Foams characterised by their intended use
    • C08J2207/10Medical applications, e.g. biocompatible scaffolds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/04Alginic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Birds (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

Une composition auto-moussante en milieu acide comprenant au moins :- un polymère hydrophile, - un composé capable de réticuler le polymère hydrophile par la formation de liaisons ioniques,- un agent moussant, et - un agent stabilisant des mousses, ladite composition étant sous la forme d’une poudre constituée de particules dont la granulométrie va de 10 nm à 2 mm et dans laquelle au moins 20% des particules présentent une granulométrie supérieure ou égale à 100 nm.
FR1872320A 2018-12-04 2018-12-04 Composition auto-moussante en milieu acide et procédé de préparation Active FR3089224B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1872320A FR3089224B1 (fr) 2018-12-04 2018-12-04 Composition auto-moussante en milieu acide et procédé de préparation
PCT/EP2019/083310 WO2020114966A1 (fr) 2018-12-04 2019-12-02 Composition auto-moussante en milieu acide et procede de preparation
EP19812775.5A EP3891188A1 (fr) 2018-12-04 2019-12-02 Composition auto-moussante en milieu acide et procede de preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1872320A FR3089224B1 (fr) 2018-12-04 2018-12-04 Composition auto-moussante en milieu acide et procédé de préparation

Publications (2)

Publication Number Publication Date
FR3089224A1 FR3089224A1 (fr) 2020-06-05
FR3089224B1 true FR3089224B1 (fr) 2020-12-11

Family

ID=65951788

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1872320A Active FR3089224B1 (fr) 2018-12-04 2018-12-04 Composition auto-moussante en milieu acide et procédé de préparation

Country Status (3)

Country Link
EP (1) EP3891188A1 (fr)
FR (1) FR3089224B1 (fr)
WO (1) WO2020114966A1 (fr)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840777A (en) 1992-06-19 1998-11-24 Albany International Corp. Method of producing polysaccharide foams
EP0612331A4 (fr) 1992-06-19 1994-11-23 Albany Int Corp Procede de production de mousses au polysaccharide.
US5750585A (en) 1995-04-04 1998-05-12 Purdue Research Foundation Super absorbent hydrogel foams
US6271278B1 (en) 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US6018033A (en) 1997-05-13 2000-01-25 Purdue Research Foundation Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same
US6677318B1 (en) 2000-09-05 2004-01-13 Beisel Guenther Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
US6696077B2 (en) 2001-07-26 2004-02-24 George H. Scherr Silver alginate foam compositions
WO2004056343A1 (fr) 2002-12-19 2004-07-08 Polymorfix, Inc. Formulations ingerables pour la reduction transitoire non invasive du volume gastrique
JP5383976B2 (ja) 2003-09-08 2014-01-08 エフエムシー バイオポリマー エイエス ゲル化バイオ重合体基材発泡体
GB0324525D0 (en) 2003-10-21 2003-11-26 British American Tobacco Co Smoking articles and smokable filler material therefor
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
FR2897529B1 (fr) 2006-02-17 2008-10-31 Cie Euro Etude Rech Paroscopie Ballon intra-gastrique a memoire de forme
ATE517645T1 (de) 2006-03-01 2011-08-15 Fmc Biopolymer As Gelierte zusammensetzung
US20070248642A1 (en) 2006-04-19 2007-10-25 Michael Dornish Foam and use thereof
AU2008266060B2 (en) 2007-06-13 2013-08-29 Fmc Corporation Alginate coated, polysaccharide gel-containing foam composite, preparative methods, and uses thereof
MX2010001629A (es) 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
EP2231212A2 (fr) 2007-12-20 2010-09-29 7L, Llc Dispositif autodilatable à avaler occupant l'espace gastrique
WO2010045482A2 (fr) 2008-10-16 2010-04-22 Obalon Therapeutics, Inc. Dispositif intragastrique
US20100100115A1 (en) 2008-10-20 2010-04-22 Wilson-Cook Medical Inc. Foam filled intragastric balloon for treating obesity
US8993539B2 (en) 2012-09-23 2015-03-31 Guang Yan Dietary fiber supplements for appetite suppression
CN105582029B (zh) * 2014-10-21 2019-12-24 上海中医药大学 鸦胆子油漂浮型胃滞留微球及其制备方法

Also Published As

Publication number Publication date
EP3891188A1 (fr) 2021-10-13
FR3089224A1 (fr) 2020-06-05
WO2020114966A1 (fr) 2020-06-11

Similar Documents

Publication Publication Date Title
WO2017180694A8 (fr) Systèmes d'édition de gènes de molécules de fusion cas9 et leurs procédés d'utilisation
EP3643745A3 (fr) Poudre comprenant du polytétrafluoroéthylène de faible masse moléculaire et ses utilisations
WO2011079279A3 (fr) Nanoconjugués et compositions de nanoconjugués
BR112018067494A2 (pt) composição anticaspa em aerossol
AR110269A1 (es) Preparación de nanopartículas de ciclodextrina para la administración de fármacos oftálmicos
WO2021062281A3 (fr) Cellules effectrices à ciblage multiple et leur utilisation
MX2018011019A (es) Composiciones de recubrimiento, recubrimientos de barrera elastica y metodos de aplicacion de esos recubrimientos.
DE602005025083D1 (fr)
BRPI0705488A (pt) composição nanoparticulada estável, métodos de preparar a mesma e de prevenir e/ou tratar uma infecção bacteriana, composição farmacêutica, e, forma de dosagem
WO2009132265A3 (fr) Composés dégradables et leurs procédés d'utilisation, impliquant en particulier une répartition des particules dans des matrices non mouillantes
BR112017000860A2 (pt) composição de resina de polímero e artigos formados com a composição
ATE457326T1 (de) Polymer
WO2010030342A3 (fr) Polymères d'héparosane et leurs procédés de fabrication et d'utilisation destinés à l'amélioration de composés thérapeutiques
FR3089224B1 (fr) Composition auto-moussante en milieu acide et procédé de préparation
BR112017002569A2 (pt) composições adesivas compreendendo polímeros à base de olefina funcionalizados de baixo peso molecular
MX2008011256A (es) Dispersiones polimericas que comprenden sustancias de efecto y uso de las mismas.
FR3023284B1 (fr) Grave agglomeree scellee pour couche d'assise comprenant une forte proportion en gros granulats
MX2022003394A (es) Arnm que codifica cftr manipulado.
BR112017008119A2 (pt) processo para dispersar partículas em uma composição de resina preenchida.
NO20076628L (no) Nanopartikkulaere sammensetninger med kontrollert frigjoring som omfatter arylheterosykliske forbindelser
EP4295904A3 (fr) Utilisation de glutamine synthétase pour le traitement de l'hyperammoniémie
WO2017120098A8 (fr) Nanoparticules polymères stimulables, procédés de fabrication de nanoparticules polymères stimulables, et procédés d'utilisation de nanoparticules polymères stimulables
BR112017025503A2 (pt) composições à base de polímero preenchido com baixa viscosidade, boas propriedades mecânicas e adesão
BR112022011449A2 (pt) Formulação para uso em um sistema gerador de aerossol
WO2018218161A3 (fr) Méthodes et compositions pour régulariser l'homéostasie du glucose

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200605

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6